喉頭がんの集団検診 : 第2報 高危険群における疾病分布,特に喉頭がんの頻度について
スポンサーリンク
概要
- 論文の詳細を見る
Fairly good results have already been obtained in the treatment of laryngeal cancer. The five year cure rate is approximately 70 percent. However, in the patients with Stage III or IV laryngeal carcinomas, nearly 75% of 5 year survivors have lost their larynx. In order to get better cure rate without sacrificing the larynx, it is necessary to detect carcinoma in its earlier stage. Mass screening will undoubtedly offer the best opportunity of earlier detection. But, because of low incidence of laryngeal cancer, mass screening must inevitably be limitted to some peoples who are thought to be high risk to laryngeal cancer. In our country, mass screenings for cancers of the lung, stomach, uterus and breast have already generally been carried out and are highly appreciated because many early carcinomas were detected, but the detection rates of these mass screenings are less than 0.2%.If, the detection rate of mass screening were better than those of these cancers, the screening is thought to be "effective"In this study, the "laryngeal cancer high risk group" was defined to those peoples who are older than 50 years and have horseness. Disease distribution, especially the incidence of laryn-geal cancer, in this high risk group was studied. This study was cooperated by 53 ENT doctors who work in their private clinics. All patients who visited these private clinics and belonged to high risk group were registered.The number of registered patients amounted to 981. In these patients, 16 laryngeal carcinomas (1.7%) and 7 hypopharyngeal carcinomas (0.7%) were detected. This detection rate was far more excellent than I expected. This result may indicate the possibility to standardize the mass screening for laryngeal cancer. I conclude that the mass screening of laryngeal cancer is thought to be quite effective and practical method, if it is carried out for the high risk group.
- 社団法人 日本耳鼻咽喉科学会の論文
著者
関連論文
- I-A-3. 頚部食道癌の進展形式(第27回食道疾患研究会)
- 下咽頭頚部食道癌の手術 : 遊離空腸移植による再建
- 頭頚部癌--とくにSalvage operationの意義 (第20回日本癌治療学会総会特別演題-2-) -- (再発癌の治癌(シンポジウム))
- マイクロサ-ジャリ-による頭頚部癌切除後の再建手術
- 頚部転移癌の原発巣診断(臨床ノ-ト)
- 8. 食道癌の細胞診(V 一般講演(消化器に関するもの), 第6回 日本臨床細胞学会講演要旨)
- 肺癌と喉頭癌の合併例の臨床的考察 : 肺癌との重複癌I
- 舌全摘出術例の術後機能評価
- 喉頭がん集団検診 : 第3報 第1回集団検診を実施して
- 中咽頭側壁悪性腫瘍の臨床像
- CC-7 游離空腸による胸部, 頸部食道の再建術(第28回日本消化器外科学会総会)
- 示-17 食道癌放射線治療後に発生した, 食道気管瘻治癒の一例(第25回日本消化器外科学会総会)
- CC-22 遊離空腸移植による頸部食道再建(第21回日本消化器外科学会総会)
- 喉頭がんの集団検診 : 第2報 高危険群における疾病分布,特に喉頭がんの頻度について
- 嗄声持続期間より推定した声帯がんの発育速度のいろいろ
- 喉頭がんの集団検診 : 第1報 耳鼻咽喉科専門医に対するアンケートの結果報告
- 舌がんの予後に影響を及ぼす因子の研究 : 舌可動部がん221例の分析より
- 上咽頭癌の治療成績 : 予後に影響を及ぼす因子の分析
- Chemotherapy for advanced head and neck cancer with CDDP, peplomycin and MTX.
- 喉頭部分切除術42例の検討
- 頭頚部がんの再建外科的治療
- 頚部転移癌の原発巣診断(臨床ノ-ト)
- 121.舌癌症例の組織悪性度からみた臨床的研究
- 舌癌症例と組織学的悪性度
- 喉頭癌リンパ節転移組織からのHuman papillomavirus(HPV)DNAの検出
- 上顎洞がんに対する放射線と手術の併用治療の検討
- 上顎洞がんに対する放射線と手術の併用治療の検討
- 上咽頭癌におけるEpstein-Barr virusの関与とその臨床的病理学的意義
- 上咽頭癌の治療成績
- An evaluation of arterial chemotherapy in the treatment of carcinoma of maxillary sinus
- 上顎洞癌224例の遠隔成績
- 上咽頭癌の治療成績および生存率に影響を及ぼす因子の分析
- 頭頸部臓器に初発した悪性リンパ腫
- Paragangliomas of the head and neck. A report of three cases and a review of the Japanese literature.:-A Report of Three Cases and a Review of the Japanese Literature-
- 頭頸部における重複癌:喉頭癌を中心に
- 喉頭がん治療成績の検討
- 喉頭がん根治照射後手術症例の臨床的,病理学的検討